Literature DB >> 12705891

Amyloidogenic synthetic peptides of beta2-microglobulin--a role of the disulfide bond.

Kazuhiro Hasegawa1, Yumiko Ohhashi, Itaru Yamaguchi, Naoki Takahashi, Shinobu Tsutsumi, Yuji Goto, Fumitake Gejyo, Hironobu Naiki.   

Abstract

To search for the essential regions responsible for the beta2-microglobulin (beta2-m) amyloid fibril formation, we synthesized six peptides corresponding to six of the seven beta-sheets in the native structure of beta2-m, and examined their amyloidogenicity. Among the peptides examined, peptide (21-31) (strand B) and the mixture of peptide (21-31) and (78-86) (strand F) showed fibril formation at both pH 2.5 and 7.5. Peptide (21-31) is the N-terminal half of the previously reported proteolytic fragment of beta2-m, Ser21-Lys41 (K3), suggesting that this region may be the essential core. Interestingly, the dimer formation of peptide (21-31) by the disulfide bond substantially facilitated the fibril formation, indicating that the disulfide bond is important for the structural stability of the fibrils.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12705891     DOI: 10.1016/s0006-291x(03)00543-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Stacked sets of parallel, in-register beta-strands of beta2-microglobulin in amyloid fibrils revealed by site-directed spin labeling and chemical labeling.

Authors:  Carol L Ladner; Min Chen; David P Smith; Geoffrey W Platt; Sheena E Radford; Ralf Langen
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

2.  Switch region for pathogenic structural change in conformational disease and its prediction.

Authors:  Xin Liu; Ya-Pu Zhao
Journal:  PLoS One       Date:  2010-01-11       Impact factor: 3.240

3.  Increase in the conformational flexibility of beta 2-microglobulin upon copper binding: a possible role for copper in dialysis-related amyloidosis.

Authors:  James Villanueva; Masaru Hoshino; Hidenori Katou; József Kardos; Kazuhiro Hasegawa; Hironobu Naiki; Yuji Goto
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

4.  K3 fragment of amyloidogenic beta(2)-microglobulin forms ion channels: implication for dialysis related amyloidosis.

Authors:  Mirela Mustata; Ricardo Capone; Hyunbum Jang; Fernando Teran Arce; Srinivasan Ramachandran; Ratnesh Lal; Ruth Nussinov
Journal:  J Am Chem Soc       Date:  2009-10-21       Impact factor: 15.419

5.  The mechanism of enhanced insulin amyloid fibril formation by NaCl is better explained by a conformational change model.

Authors:  Mahvish Muzaffar; Atta Ahmad
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

6.  Fibril growth kinetics reveal a region of beta2-microglobulin important for nucleation and elongation of aggregation.

Authors:  Geoffrey W Platt; Katy E Routledge; Steve W Homans; Sheena E Radford
Journal:  J Mol Biol       Date:  2008-02-12       Impact factor: 5.469

7.  Prediction of "hot spots" of aggregation in disease-linked polypeptides.

Authors:  Natalia Sánchez de Groot; Irantzu Pallarés; Francesc X Avilés; Josep Vendrell; Salvador Ventura
Journal:  BMC Struct Biol       Date:  2005-09-30

8.  Competition between intramolecular and intermolecular interactions in an amyloid-forming protein.

Authors:  Katy E Routledge; Gian Gaetano Tartaglia; Geoffrey W Platt; Michele Vendruscolo; Sheena E Radford
Journal:  J Mol Biol       Date:  2009-04-23       Impact factor: 5.469

9.  Globular tetramers of beta(2)-microglobulin assemble into elaborate amyloid fibrils.

Authors:  Helen E White; Julie L Hodgkinson; Thomas R Jahn; Sara Cohen-Krausz; Walraj S Gosal; Shirley Müller; Elena V Orlova; Sheena E Radford; Helen R Saibil
Journal:  J Mol Biol       Date:  2009-04-05       Impact factor: 5.469

Review 10.  Glimpses of the molecular mechanisms of beta2-microglobulin fibril formation in vitro: aggregation on a complex energy landscape.

Authors:  Geoffrey W Platt; Sheena E Radford
Journal:  FEBS Lett       Date:  2009-05-09       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.